The use of such device that simultaneously determines AbsCD4, CD4% and Hb levels from capillary and/or venous blood would simplify the routine monitoring of patients with HIV/AIDS and be particularly beneficial in resource-constrained settings. This evidence concerns the gene CD4 and AIDS.